Reed Smith, Freshfields, Kirkland on Henlius’ $691 mln take-private deal
BY Hu Yangxiaoxiao 胡阳潇潇 |
Freshfields Bruckhaus Deringer is representing Hong Kong-listed biotech company Henlius on its $691 million take-private deal offer from Shanghai Fosun New Medicine Research Company, which is being advised by Reed Smith.